The Heart Rhythm Society and Consumer Technology Association will debut new consumer guidelines this week focused on wearables that detect and monitor cardiovascular metrics.

Despite its diagnostic and prognostic value, speckle-tracking strain echocardiography is underused, some cardiac imagers say. What will it take for adoption to pick up?

Abbott’s transcatheter tricuspid valve repair system is a safe and effective approach to treating tricuspid regurgitation in heart patients with few other options, according to data published in The Lancet.

Nearly 93% of the U.S. population lives in a hospital referral region with at least one medical center that performs 25 or more mitral valve repairs or replacements each year, according to work published in JAMA Cardiology—but MVRR centers continue to suffer from significant geographical and patient-level disparities.

The latest numbers on cardiovascular deaths put the focus on innovative ways to point the trend line down again.

Urine flow rate-guided hydration, as opposed to left ventricular end-diastolic pressure-guided hydration, could prevent more complications in CKD patients who are at a high risk for contrast-induced kidney injury.

Results from the late-breaking TWILIGHT trial suggest that, among high-risk patients who have undergone PCI and completed three months of dual antiplatelet therapy, it’s safer to continue treatment with ticagrelor alone rather than add aspirin to that cocktail.

Patients with severe aortic stenosis who undergo TAVR enjoy a minor but significant sustained health benefit that isn’t mirrored in patients who opt for surgical AVR, according to research reported at TCT 2019 in San Francisco.